Frezent Biological Solutions Inc.

New York, NY

UEI
TYN7L1WR9NH4
CAGE
7WWH8
Primary NAICS
541714 Research and Development in Biotechnology (except Nanobiotechnology)
SAM.gov registration
Active through

Company facts

Self-certified in SAM.gov
  • For Profit Organization
  • Woman Owned Small Business
  • Woman Owned Business
Entity structure
Corporate Entity (Not Tax Exempt)
NAICS codes registered in SAM.gov
SAM.gov registration date
Physical address
269 W 71st St, New York, NY 10023, USA
Website
frezent.com
Founded
2017
Employees
1-10
Estimated annual revenue
$0-$1M
Industry
  1. Health Care
  2. Pharmaceuticals, Biotechnology & Life Sciences
  3. Biotechnology
SIC code
28 Chemical & Allied Products
Profiles

Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .

Recent federal awards

Frezent Biological Solutions Inc.'s latest federal award, newest first. Amounts are dollars obligated.
Award Agency Obligated Awarded
Sbir phase i: development of a novel peptide inhibitor of coronavirus papain-like protease as a prophylactic and… Grant · 2036294 Division of Industrial Innovation $255,981

Quick answers

What is Frezent Biological Solutions Inc.'s UEI?

Frezent Biological Solutions Inc.'s Unique Entity ID (UEI) in SAM.gov is TYN7L1WR9NH4.

What is Frezent Biological Solutions Inc.'s CAGE code?

Frezent Biological Solutions Inc.'s CAGE code is 7WWH8.

What is Frezent Biological Solutions Inc.'s primary NAICS code?

Frezent Biological Solutions Inc.'s primary NAICS code is 541714 (Research and Development in Biotechnology (except Nanobiotechnology)).

Where is Frezent Biological Solutions Inc. located?

Frezent Biological Solutions Inc.'s physical address in SAM.gov is 269 W 71st St, New York, NY 10023, USA.

Is Frezent Biological Solutions Inc. registered in SAM.gov?

Yes. Frezent Biological Solutions Inc.'s SAM.gov registration is active through August 5, 2027.

What is Frezent Biological Solutions Inc.'s most recent federal award?

Frezent Biological Solutions Inc.'s most recent federal grant award is Sbir phase i: development of a novel peptide inhibitor of coronavirus papain-like protease as a prophylactic and… (2036294), from Division of Industrial Innovation, on February 15, 2021.

On GovTribe

See Frezent Biological Solutions Inc.'s full federal record

  • Federal grant awards
  • Funding analysis by agency, NAICS and set-aside
  • Similar vendors
Try for free Login